Skip to content

Future Patient - Telerehabilitation of Heart Failure Patients

Future Patient - Telerehabilitation of Heart Failure Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03388918
Enrollment
140
Registered
2018-01-03
Start date
2016-12-21
Completion date
2019-08-01
Last updated
2021-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Decompensated Heart Failure, Heart Failure NYHA Class I, Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure NYHA Class IV

Keywords

Quality of life, Telerehabilitation, Cardiac patients, Heart failure

Brief summary

The idea behind the Future Patient research project is to develop a telerehabilitation program and tools for patients with heart failure. The hypothesis for this study is that participation in a telerehabilitation program for patients with heart failure will increase the patients' quality of life and multi-parametric (subjective and objective) individualized monitoring in a telerehabilitation program for patients with heart failure will increase detection of worsening of symptoms and avoid future hospitalization of the HF-patients.

Detailed description

The overall aim is to test, implement and evaluate a telerehabilitation program for patients with heart failure from clinical, psychosocial, health literacy and e-health literacy, inter-organizational, health economic and technical perspectives. Furthermore, this study has sub aims: * To increase the quality of life for patients with Heart Failure (HF) * To optimize the medical treatment of patients with HF * To perform multi-parametric (subjective and objective) individualized monitoring in order to detect worsening of symptoms and avoid hospitalizations * To increase physical activities for patients with heart failure in everyday life in a telerehabilitation program * To facilitate patient-initiated self-care management actions upon the following early detection of changes in source data (steps taken, weight, blood pressure, pulse, sleep, illness perception, motivation, anxiety and depression) * To evaluate patients health literacy and e-health literacy participating in a telerehabilitation program and rehabilitation program * To test and evaluate the Heart Portal - a digital toolbox for improved self-management for patients with heart failure and their relatives * To explore the experiences and perspectives of the patients and their relatives when being part of a telerehabilitation program * To test and evaluate a cross sector communication platform from a patient and healthcare professional perspective * To perform a cost-effectiveness analysis of total costs of healthcare and rehabilitation services

Interventions

DEVICETelerehabilitation

Blood pressure (A&D Medical UA 767PBT), weight (A&D Medical UC-321PBT), step counters(Fitbit Zip & Charge), sleep sensor (Beddit 3), tablet (iPAD Air 2) & transmitter (Qualcomm Life, QWH-HUB-V1.0E)

Sponsors

Aage og Johanne Louis-Hansens Fond
CollaboratorOTHER
Viewcare A/S
CollaboratorUNKNOWN
Laboratory of Welfare Technologies - Telehealth & Telerehabilitation, SMI, Department of Health Science and Technology, Aalborg University
CollaboratorUNKNOWN
Regionshospitalet Viborg, Skive
CollaboratorOTHER
Technical University of Denmark
CollaboratorOTHER
University of Aarhus
CollaboratorOTHER
Danish Heart Foundation
CollaboratorOTHER
Viborg Healthcare Center
CollaboratorUNKNOWN
Skive Healthcare Center
CollaboratorUNKNOWN
Odense University Hospital
CollaboratorOTHER
Department of Computer Science, AAU
CollaboratorUNKNOWN
Aalborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomised controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with HF according to New York Heart Association (NYHA) Class I-IV with max 20 % in class I or who have a current hospitalization for acute decompensated HF within the past two weeks * Adults (18 years or older); no upper age limit * Patients living in Viborg and Skive Municipality * Living at home and capable of caring for him/herself * Have basic computer skills or a relative who have basic computer skills * Informed consent to participate in a telerehabilitation program * May have a pacemaker

Exclusion criteria

* Pregnancy * Drug addiction defined as the use of cannabis, opioids or other drugs * Previous neurologic, musculoskeletal or cognitive disability or active psychiatric history (as noted in the medical record) other than depression or anxiety related to cardiac or other chronic illness * Lack of ability to cooperate * Does not speak Danish

Design outcomes

Primary

MeasureTime frameDescription
Increased quality of lifeIntervention group: At baseline, week 2,4,6,8,10,12,14,16,18,20,22,24,26,28,30,32, 34,36,38,40,42,44,46,48,50,52 Control group: Baseline, 6 & 12 monthsIncreased quality of life as measured by a moderate change (10 points) in quality of life measured by Kansas City Questionnaire (KCCQ)

Secondary

MeasureTime frameDescription
Time from baseline to optimized medical treatmentFor both intervention and control group: From date of randomization until the date of first documented progression with medical treatment, assessed up to 4 monthsTime for optimizing medicine
All cause hospitalizationFor both intervention and control group: 6 monthsAll-cause hospitalization at end of rehabilitation
Steps takenIntervention group: Everyday for 12 monthsNumbers of steps taken in the intervention group
Development of bloodpressureIntervention group: Blood pressure (mmHG) from date of randomization twice a week assessed up to 3 monthsIntervention group: Blood pressure (mmHG)
Development of pulseIntervention group: Pulse from date of randomization and every day in 12 monthsIntervention group: Pulse ( numbers per minutes)
Development of weightIntervention group: Weight from date of randomization and every day in 12 monthsIntervention group: Weight (Kilograms)
SleepIntervention group: Sleep from date of randomization and accessed up to 12 monthsIntervention group: Sleep ( numbers of hours per night)
Illness perceptionFor Intervention and control group: At baseline, 6 & 12 monthsPositive changes in illness perceptions, from dysfunctional to functional measured by Illness perception questionaire
MotivationFor both intervention and control group: At baseline, 6 & 12 monthsChanges from extrinsic to intrinsic motivation measured from baseline to end of rehabilitation and 6 months after end of rehabilitation measured by Health Climate Change Questionaire
Anxiety and depressionFor both intervention and control group: At baseline, 6 & 12 monthsExplore whether levels of anxiety and depression in the intervention group are lower or equivalent to the control group measured by Hospital Anxiety and Depression Scale (HADS) questionnaire
Health- literacyFor both intervention and control group: At baselineHealth literacy in intervention and control group measured by Health Literacy Questionnaire (Danish validated version HLQ) by units on a scale
eHealth literacyFor both intervention and control group: At baseline, 6 & 12 monthsImprovement in e-health literacy in intervention and control group measured by eHealth Literacy Questionnaire (Danish validated version eHLQ) by units on a scale
Experiences of using the Heart portalFor intervention group: 6 & 12 monthsQualitative exploration of experiences of HF patients, relatives and healthcare professionals use of the Heart portal
Costs of healthcare and rehabilitation servicesFor both intervention and control group: 6 monthsNumber of hospitalizations, number of contacts with heart failure clinic, days at hospital, contacts with general practitioners, number of participations in rehabilitation activities at healthcare center between intervention and control group

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026